跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stadavas Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stadavas Plus
Approved
STANDARD
Stadavas Plus
Watson Pharma Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
194e67eaee6d1b78
Company
Watson Pharma Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
194e67eaee6d1b78
Drug Approval Philippines Name
Stadavas Plus
Product Name
Stadavas Plus
Registration Number
DR-XY48441
Brand Name
Stadavas Plus
Generic Name
Simvastatin + Ezetimibe
Dosage Form
Tablet
Dosage Strength
80 mg/ 10 mg
Manufacturer
Watson Pharma Pvt. Ltd.
Importer
STADA Philippines Inc
Distributor
STADA Philippines Inc
Issuance Date
28 October 2022
Expiry Date
28 October 2027
Pharmacologic Category
Lipid Modifying Agents
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
194e67eaee6d1b78
Type
Standard
Back to Philippines FDA Approvals